These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 9731851)

  • 1. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
    Thys-Jacobs S; Starkey P; Bernstein D; Tian J
    Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium supplementation in premenstrual syndrome: a randomized crossover trial.
    Thys-Jacobs S; Ceccarelli S; Bierman A; Weisman H; Cohen MA; Alvir J
    J Gen Intern Med; 1989; 4(3):183-9. PubMed ID: 2656936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premenstrual and menstrual symptom clusters and response to calcium treatment.
    Alvir JM; Thys-Jacobs S
    Psychopharmacol Bull; 1991; 27(2):145-8. PubMed ID: 1924661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
    Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
    Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.
    Doll H; Brown S; Thurston A; Vessey M
    J R Coll Gen Pract; 1989 Sep; 39(326):364-8. PubMed ID: 2558186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. progesterone Study Group.
    Magill PJ
    Br J Gen Pract; 1995 Nov; 45(400):589-93. PubMed ID: 8554838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
    Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
    Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder.
    Freeman EW; Sondheimer SJ; Sammel MD; Ferdousi T; Lin H
    J Clin Psychiatry; 2005 Jun; 66(6):769-73. PubMed ID: 15960573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
    Schmidt PJ; Grover GN; Rubinow DR
    Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.
    Sundblad C; Hedberg MA; Eriksson E
    Neuropsychopharmacology; 1993 Sep; 9(2):133-45. PubMed ID: 8216696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial.
    Fanaei H; Khayat S; Kasaeian A; Javadimehr M
    Neuropeptides; 2016 Apr; 56():25-31. PubMed ID: 26608718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol.
    O'Brien PM; Abukhalil IE
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):18-23. PubMed ID: 9914571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
    Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
    Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
    Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M;
    J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
    Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
    N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.
    Steiner M; Ravindran AV; LeMelledo JM; Carter D; Huang JO; Anonychuk AM; Simpson SD
    J Clin Psychiatry; 2008 Jun; 69(6):991-8. PubMed ID: 18517289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a nutritional supplement on premenstrual symptomatology in women with premenstrual syndrome: a double-blind longitudinal study.
    London RS; Bradley L; Chiamori NY
    J Am Coll Nutr; 1991 Oct; 10(5):494-9. PubMed ID: 1955626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study.
    Gerhardsen G; Hansen AV; Killi M; Fornitz GG; Pedersen F; Roos SB
    Adv Ther; 2008 Jun; 25(6):595-607. PubMed ID: 18568441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.